Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AGER: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A gene referenced in 143 knowledge graph relationships. Key connections: mediates Microglia Activation (process); activates Microglial Activation (process); activates Microglia Activation (process).
No AI portrait yet
| Gene Symbol | AGER |
| Full Name | RAGE |
| Chromosome | 6p21.3 |
| Protein Type | Receptor |
| Target Class | Protein |
| Function | RAGE is a multi-ligand receptor that binds: - Advanced glycation end products (AGEs) - HMGB1 (High Mobility Group Box 1) - S100B protein - Amyloid-beta fibrils - DNA release from damaged cells |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuroinflammatory Cascade |
| Druggability | Undruggable (0.23) |
| Pathways | NF-κB, MAPK |
| UniProt ID | Q15120 |
| NCBI Gene ID | 177 |
| OMIM | 600841 |
| GeneCards | AGER |
| Human Protein Atlas | AGER |
| Associated Diseases | AD, ALI, als, Alzheimer's disease |
| Known Drugs/Compounds | CHEMBL2179074, CHEMBL2205553, CHEMBL2205552, CHEMBL2205550, CHEMBL2205549, CHEMBL2205572 |
| Interactions | EGFR, HER2, HLA, HSPA1A, HSPA1B, NCOA4 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | Blocking AGE-RAGE Signaling in Enteric Glia to Pre |
| KG Connections | 144 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
A["AGER"] --> B["RAGE Signaling"]
A --> C["AGE Ligand Binding"]
C --> B
B --> D["NF-kB Activation"]
D --> E["Pro-inflammatory Cytokines"]
B --> F["Oxidative Stress"]
E --> G["Chronic Neuroinflammation"]
F --> G
G --> H["Blood-Brain Barrier Dysfunction"]
G --> I["Neuronal Apoptosis"]
I --> J["Cognitive Decline"]| Target | Relation | Type | Str |
|---|---|---|---|
| Microglial Activation | activates | process | 0.90 |
| Microglia Activation | mediates | process | 0.90 |
| Microglia Activation | activates | process | 0.89 |
| Alzheimer's Disease | involved_in | disease | 0.85 |
| Inflammation | promotes | process | 0.85 |
| Alzheimer'S Disease | involved_in | disease | 0.85 |
| Blood-Brain Barrier | involved_in | process | 0.80 |
| Inflammatory Response | activates | process | 0.80 |
| APP | binds | protein | 0.80 |
| MICROVASCULAR_COMPLICATIONS | associated_with | phenotype | 0.72 |
| ALS | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| HSPA1A | associated_with | gene | 0.60 |
| spinal cord | expressed_in | brain_region | 0.60 |
| RAGE | expressed_in | gene | 0.60 |
| HLA | interacts_with | gene | 0.60 |
| HSPA1B | associated_with | gene | 0.60 |
| HLA | associated_with | gene | 0.60 |
| ALS | protects_against | gene | 0.60 |
| TLR4 | associated_with | gene | 0.60 |
| NCOA4 | inhibits | gene | 0.60 |
| SOD1G93A | expressed_in | gene | 0.60 |
| SOD1G93A | protects_against | gene | 0.60 |
| ALS | expressed_in | gene | 0.60 |
| neural stem cells | expressed_in | cell_type | 0.60 |
| lipid metabolism | participates_in | pathway | 0.60 |
| microglia | expressed_in | cell_type | 0.60 |
| microglia | protects_against | cell_type | 0.60 |
| NF-kB signaling | participates_in | pathway | 0.60 |
| HSPA1A | interacts_with | gene | 0.60 |
| HSPA1B | interacts_with | gene | 0.60 |
| RAGE | regulates | gene | 0.55 |
| lung cancer | interacts_with | disease | 0.50 |
| SOD1G93A | associated_with | gene | 0.50 |
| neuron | regulates | cell_type | 0.50 |
| EGFR | activates | gene | 0.50 |
| T cell | activates | cell_type | 0.50 |
| SOD1G93A | regulates | gene | 0.50 |
| GR | associated_with | gene | 0.50 |
| type 2 diabetes | implicated_in | disease | 0.50 |
| metabolic diseases | implicated_in | disease | 0.50 |
| RAGE | associated_with | gene | 0.50 |
| GLO1 | associated_with | gene | 0.50 |
| CD33 | therapeutic_target | gene | 0.50 |
| DLL3 | therapeutic_target | gene | 0.50 |
| AD | implicated_in | disease | 0.50 |
| ALI | implicated_in | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-8f285020 | targets_gene | hypothesis | 0.90 |
| HSPA1A | associated_with | gene | 0.60 |
| HSPA1B | associated_with | gene | 0.60 |
| h-8f285020 | targets | hypothesis | 0.50 |
| TIA1L Protein | references | protein | 0.40 |
| TDC | co_discussed | gene | 0.40 |
| TLR4 | co_discussed | gene | 0.40 |
| DDC | co_discussed | gene | 0.40 |
| GPR109A | co_discussed | gene | 0.40 |
| CHRNA7 | co_discussed | gene | 0.40 |
| HDAC | co_discussed | gene | 0.40 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro | 0.613 | neurodegeneration | What are the mechanisms by which gut mic |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.907
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| AGE-mediated HCC induction in animal models with β-catenin signaling | validation | Hepatocellular carcinoma | 0.900 | 0.00 | animal models (species not spe | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Decoding cell death signals in liver inflammation. [PMID:23567086] | Brenner C, Galluzzi L, Kepp O, Kroemer G | J Hepatol | 2013 | 1 |
| Wnt-dependent modulation of alveolar epithelial phenotypes and barrier function [PMID:41678947] | Lin YC, Igarashi M, Sakai Y, Nishikawa M | Biochem Biophys Res Commun | 2026 | 0 |
| Luteolin targets the AGE-RAGE signaling to mitigate inflammation and ferroptosis [PMID:38917486] | Zhang N, Chen P, Liang X, Sun J, Liu Q, | Aging | 2024 | 0 |
| Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic li [PMID:38297127] | Fan W, Adebowale K, Váncza L, Li Y, Rabb | Nature | 2024 | 0 |
| Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming a [PMID:36154605] | ["Koerich S", "Parreira G", "de Almeida | Current neuropharmacology | 2023 | 0 |
| Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR [PMID:37442582] | Strickson S, Houslay KF, Negri VA, Ohne | The European respiratory journ | 2023 | 0 |
| Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 [PMID:34130712] | ["MacLean M", "Juranek J", "Cuddapah S", | Journal of neuroinflammation | 2021 | 0 |
| Bi-allelic loss of function variants in SLC30A5 as cause of perinatal lethal car [PMID:33547425] | Lieberwirth JK, Joset P, Heinze A, Hents | European journal of human gene | 2021 | 0 |
| Environmental Regulation, Technological Innovation, and Export Competitiveness: [PMID:32102174] | Liu J, Xie J | International journal of envir | 2020 | 0 |
| Predicting Subjective Recovery from Lower Limb Surgery Using Consumer Wearables. [PMID:33442582] | Karas M, Marinsek N, Goldhahn J, Foschin | Digital biomarkers | 2020 | 0 |
| Glycation & the RAGE axis: targeting signal transduction through DIAPH1. [PMID:27967251] | ["Shekhtman A", "Ramasamy R", "Schmidt A | Expert review of proteomics | 2017 | 0 |
| The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases. [PMID:29259621] | ["Senatus L", "Schmidt A"] | Frontiers in genetics | 2017 | 0 |
| Diabetes and Alzheimer's disease crosstalk. [PMID:26969101] | Baglietto-Vargas D, Shi J, Yaeger DM, Ag | Neuroscience and biobehavioral | 2016 | 0 |
| Pathophysiological Links Among Hypertension and Alzheimer's Disease. [PMID:26054481] | Carnevale D, Perrotta M, Lembo G, Trimar | High blood pressure & cardiova | 2016 | 0 |
| High-fructose intake as risk factor for neurodegeneration: Key role for carboxy [PMID:26851500] | ["Mastrocola R", "Nigro D", "Cento A", " | Neurobiology of disease | 2016 | 0 |
| [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for c [PMID:25486663] | Barbezier N, Tessier FJ, Chango A | Annales de biologie clinique | 2014 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning AGER in their description or question text
No additional research found